Literature DB >> 15294005

O-alkoxyamidine prodrugs of furamidine: in vitro transport and microsomal metabolism as indicators of in vivo efficacy in a mouse model of Trypanosoma brucei rhodesiense infection.

John H Ansede1, Mariappan Anbazhagan, Reto Brun, Judy D Easterbrook, James Edwin Hall, David W Boykin.   

Abstract

Five O-alkoxyamidine analogues of the prodrug 2,5-bis[4-methoxyamidinophenyl]furan were synthesized and evaluated against Trypanosoma brucei rhodesiense in the STIB900 mouse model by oral administration. The observed in vivo activity of these prodrugs demonstrates that compounds with an O-methoxyamidine or O-ethoxyamidine group effectively cured all trypanosome-infected mice, whereas prodrugs with larger side-chains did not completely cure the mice. Permeability across Caco-2 cell monolayers and microsomal metabolism were used to identify the underlying mechanisms of prodrug efficacy. Copyright 2004 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15294005     DOI: 10.1021/jm030604o

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  18 in total

Review 1.  Antiparasitic compounds that target DNA.

Authors:  W David Wilson; Farial A Tanious; Amanda Mathis; Denise Tevis; James Edwin Hall; David W Boykin
Journal:  Biochimie       Date:  2008-03-04       Impact factor: 4.079

2.  Synthesis and antiprotozoal activity of dicationic 2,6-diphenylpyrazines and aza-analogues.

Authors:  Laixing Hu; Alpa Patel; Lavanya Bondada; Sihyung Yang; Michael Zhuo Wang; Manoj Munde; W David Wilson; Tanja Wenzler; Reto Brun; David W Boykin
Journal:  Bioorg Med Chem       Date:  2013-08-13       Impact factor: 3.641

3.  Synthesis of novel amide and urea derivatives of thiazol-2-ethylamines and their activity against Trypanosoma brucei rhodesiense.

Authors:  Donald A Patrick; Tanja Wenzler; Sihyung Yang; Patrick T Weiser; Michael Zhuo Wang; Reto Brun; Richard R Tidwell
Journal:  Bioorg Med Chem       Date:  2016-04-02       Impact factor: 3.641

4.  Urea Derivatives of 2-Aryl-benzothiazol-5-amines: A New Class of Potential Drugs for Human African Trypanosomiasis.

Authors:  Donald A Patrick; J Robert Gillespie; Joshua McQueen; Matthew A Hulverson; Ranae M Ranade; Sharon A Creason; Zackary M Herbst; Michael H Gelb; Frederick S Buckner; Richard R Tidwell
Journal:  J Med Chem       Date:  2016-12-19       Impact factor: 7.446

5.  Understanding the DNA binding of novel non-symmetrical guanidinium/2-aminoimidazolinium derivatives.

Authors:  Padraic S Nagle; Susan J Quinn; John M Kelly; Daniel H O'Donovan; Amir R Khan; Fernando Rodriguez; Binh Nguyen; W David Wilson; Isabel Rozas
Journal:  Org Biomol Chem       Date:  2010-10-15       Impact factor: 3.876

6.  Structure-dependent binding of arylimidamides to the DNA minor groove.

Authors:  Yun Chai; Manoj Munde; Arvind Kumar; Leah Mickelson; Sen Lin; Nancy H Campbell; Moloy Banerjee; Senol Akay; Zongying Liu; Abdelbasset A Farahat; Raja Nhili; Sabine Depauw; Marie-Hélène David-Cordonnier; Stephen Neidle; W David Wilson; David W Boykin
Journal:  Chembiochem       Date:  2013-12-09       Impact factor: 3.164

7.  New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289.

Authors:  Tanja Wenzler; David W Boykin; Mohamed A Ismail; James Edwin Hall; Richard R Tidwell; Reto Brun
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

8.  Synthesis and antiprotozoal activity of cationic 1,4-diphenyl-1H-1,2,3-triazoles.

Authors:  Stanislav A Bakunov; Svetlana M Bakunova; Tanja Wenzler; Maedot Ghebru; Karl A Werbovetz; Reto Brun; Richard R Tidwell
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

Review 9.  Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

Authors:  M P Barrett; D W Boykin; R Brun; R R Tidwell
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

10.  Safety, pharmacokinetic, and efficacy studies of oral DB868 in a first stage vervet monkey model of human African trypanosomiasis.

Authors:  John K Thuita; Kristina K Wolf; Grace A Murilla; Qiang Liu; James N Mutuku; Yao Chen; Arlene S Bridges; Raymond E Mdachi; Mohamed A Ismail; Shelley Ching; David W Boykin; James Edwin Hall; Richard R Tidwell; Mary F Paine; Reto Brun; Michael Zhuo Wang
Journal:  PLoS Negl Trop Dis       Date:  2013-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.